TREATMENT OF TYPE 2 DIABETES MELLITUS WITH GLP-1 RECEPTOR AGONISTS, CHRONIC KIDNEY DISEASE AND INFLUENCE ON CARDIOVASCULAR RISK. TJS [Internet]. 2025 Oct. 20 [cited 2025 Oct. 22];23(Supplement 1):6. Available from: https://tjs.trakia-uni.bg/index.php/tjs/article/view/143